Elevai Biosciences, a Subsidiary of Elevai Labs (ELAB), Expands Patent Portfolio

Go back to Elevai Biosciences, a Subsidiary of Elevai Labs (ELAB), Expands Patent Portfolio
(NASDAQ: ELAB) Delayed: 0.92 -0.04 (4.17%)
Previous Close $0.96    52 Week High
Open $0.93    52 Week Low
Day High $0.96    P/E N/A 
Day Low $0.91    EPS
Volume 165,123